2
Clinical Trials associated with Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell) (Beijing Bio-Institute Biological Products)A Randomized, Double-blind, Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in a '2+1'Sequential Schedule With Bivalent Oral Poliovirus Vaccine in 2-month-old Infants
The purpose of this phrase III clinical trial is to evaluate the immunogenicity and safety of Sabin Inactivated Poliovirus Vaccine (Vero cell) in a '2+1'sequential schedule with bivalent oral poliovirus vaccine in 2-month-old infants
A Randomized, Double-blind, Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in a '1+2' Sequential Schedule With Bivalent Oral Poliovirus Vaccine in 2-month-old Infants
The purpose of this phrase III clinical trial is to evaluate the immunogenicity and safety of Sabin Inactivated Poliovirus Vaccine (Vero cell) in a '1+2' sequential schedule with bivalent oral poliovirus vaccine in 2-month-old infants
100 Clinical Results associated with Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell) (Beijing Bio-Institute Biological Products)
100 Translational Medicine associated with Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell) (Beijing Bio-Institute Biological Products)
100 Patents (Medical) associated with Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell) (Beijing Bio-Institute Biological Products)
100 Deals associated with Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell) (Beijing Bio-Institute Biological Products)